Cite
HARVARD Citation
Auliac, J. et al. (n.d.). Corrigendum to "Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study" [Lung Cancer 85 (2014) 415–419]. Lung cancer. 87 (2), pp. 210-. [Online].